From agbioscience innovation to defense, pharma, food and nutrition, and beyond – the bioeconomy is broad; and the intersection of innovation, research and policy generates a lot of questions when it comes to how we grow and scale to be a global leader right here in the United States. This week, we are joined by Sarah Glaven, Visiting Fellow at Princeton University’s Andlinger Center and a former biotechnologist representing The White House, The Pentagon and The Naval Research Laboratory. We get into:
- Sarah’s professional story, from being an outdoors kid to leading critical bioinnovation work on a national scale
- How she defines the bioeconomy and what she believes is its importance to the US’ future
- Biggest headwinds we are facing when it comes to the growth and scale of the bioeconomy
- How her past experiences have shaped her perspective on the critical alignment needed among policy, innovation and research to advance the bioeconomy in the US (and the grade she’d give us on that alignment today)
- Indiana’s position in the bioeconomy and how reshoring biomanufacturing supply chains can reduce disruption and increase competitiveness in the US
- Creating a skilled workforce to grow the bioeconomy and examples of upskilling and developing talent that have her most impressed
- What has Sarah most excited about the US’ bioinnovation future
